Simran Mangwani-Mordani

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 14

Top Topics

Randomized Controlled Trial

Neuropathic Pain

Psychometric Properties

Gas Chromatography

Top Venues

Journal of clinical medicine

Neuromodulation : journal of the International Neuromodulation Society

This page only lists publications with an associated author ORCID identifier.

Publications

Simran Mangwani-Mordani, Amanda Prislovsky, Daniel Stephenson, Charles E Chalfant, Anat Galor, Nawajes A Mandal
Role of Polyunsaturated Fatty Acids (PUFAs) and Eicosanoids on Dry Eye Symptoms and Signs. Biomolecules 14 (3) (2024)
Simran Mangwani-Mordani, Amanda Prislovsky, Daniel Stephenson, Charles E Chalfant, Anat Galor, Nawajes A Mandal
Role of Polyunsaturated Fatty Acids (PUFAs) and Eicosanoids on Dry Eye Symptoms and Signs. Biomolecules 14 (3) (2024)
David Valdés-Arias, Elyana Vittoria Tessa Locatelli, Paula A Sepulveda-Beltran, Simran Mangwani-Mordani, Juan Carlos Navia, Anat Galor
Recent United States Developments in the Pharmacological Treatment of Dry Eye Disease. Drugs (2024)
David Valdés-Arias, Elyana Vittoria Tessa Locatelli, Paula A Sepulveda-Beltran, Simran Mangwani-Mordani, Juan Carlos Navia, Anat Galor
Recent United States Developments in the Pharmacological Treatment of Dry Eye Disease. Drugs 84 (5) (2024)
David Valdés-Arias, Elyana Vittoria Tessa Locatelli, Paula A Sepulveda-Beltran, Simran Mangwani-Mordani, Juan Carlos Navia, Anat Galor
Recent United States Developments in the Pharmacological Treatment of Dry Eye Disease. Drugs 84 (5) (2024)
Simran Mangwani-Mordani, Amanda Prislovsky, Daniel Stephenson, Charles E Chalfant, Anat Galor, Nawajes A Mandal
Role of Polyunsaturated Fatty Acids (PUFAs) and Eicosanoids on Dry Eye Symptoms and Signs. Biomolecules 14 (3) (2024)
David Valdés-Arias, Elyana Vittoria Tessa Locatelli, Paula A Sepulveda-Beltran, Simran Mangwani-Mordani, Juan Carlos Navia, Anat Galor
Recent United States Developments in the Pharmacological Treatment of Dry Eye Disease. Drugs 84 (5) (2024)
David Valdés-Arias, Elyana Vittoria Tessa Locatelli, Paula A Sepulveda-Beltran, Simran Mangwani-Mordani, Juan Carlos Navia, Anat Galor
Recent United States Developments in the Pharmacological Treatment of Dry Eye Disease. Drugs 84 (5) (2024)
Lauren E Truax, Jaxon J Huang, Katherine Jensen, Elyana Vittoria Tessa Locatelli, Kimberly Cabrera, Haley O Peterson, Noah K Cohen, Simran Mangwani-Mordani, Andrew Jensen, Raquel Goldhardt, Anat Galor
Pyridostigmine Bromide Pills and Pesticides Exposure as Risk Factors for Eye Disease in Gulf War Veterans. Journal of clinical medicine 12 (6) (2023)
Lauren E Truax, Jaxon J Huang, Katherine Jensen, Elyana Vittoria Tessa Locatelli, Kimberly Cabrera, Haley O Peterson, Noah K Cohen, Simran Mangwani-Mordani, Andrew Jensen, Raquel Goldhardt, Anat Galor
Pyridostigmine Bromide Pills and Pesticides Exposure as Risk Factors for Eye Disease in Gulf War Veterans. Journal of clinical medicine 12 (6) (2023)
Lauren E Truax, Jaxon J Huang, Katherine Jensen, Elyana Vittoria Tessa Locatelli, Kimberly Cabrera, Haley O Peterson, Noah K Cohen, Simran Mangwani-Mordani, Andrew Jensen, Raquel Goldhardt, Anat Galor
Pyridostigmine Bromide Pills and Pesticides Exposure as Risk Factors for Eye Disease in Gulf War Veterans. Journal of clinical medicine 12 (6) (2023)
Liang Wang, Serena M Shah, Simran Mangwani-Mordani, Ninel Z Gregori
Updates on Emerging Interventions for Autosomal Recessive ABCA4 -Associated Stargardt Disease. Journal of clinical medicine 12 (19) (2023)
Elyana Vittoria Tessa Locatelli, Jaxon J Huang, Simran Mangwani-Mordani, Arianna A Tovar Vetencourt, Anat Galor
Individuals with Diabetes Mellitus Have a Dry Eye Phenotype Driven by Low Symptom Burden and Anatomic Abnormalities. Journal of clinical medicine 12 (20) (2023)
Divy Mehra, Simran Mangwani-Mordani, Kelly Acuna, Jodi C Hwang, Elizabeth R Felix, Anat Galor
Long-Term Trigeminal Nerve Stimulation as a Treatment for Ocular Pain. Neuromodulation : journal of the International Neuromodulation Society 24 (6) (2021)